Cytoreductive Regimen Containing Ranimustine (MCNU), Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Relapsed or Refractory Lymphoma

Authors :: Teruhisa Azuma
Shin Ichiro Mori
Yoshitaka Asakura
R. Tanosaki
Yukio Kobayashi
Takahiro Fukuda
Yoichi Takaue
Kensei Tobinai
Dai Maruyama
Sung Won Kim
Saiko Kurosawa
Kimikazu Yakushijin
Tsutomu Watanabe
Source :: Biology of Blood and Marrow Transplantation. (2):41
Publisher :: American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
Cyclophosphamide
business.industry
Hematology
Ranimustine
Regimen
Internal medicine
medicine
Peripheral Blood Stem Cell Transplantation
Refractory lymphoma
business
Carboplatin/etoposide
medicine.drug

Full Text Access

Tools